Akkaraju Srinivas's Form 4 filing
LENZ Therapeutics, Inc. (LENZ) · filed Jan 21, 2022
- Accession no.
- 0001209191-22-004346
- Filed
- Jan 21, 2022, 1:48 PM ET
- Trade date
- Jan 19-20, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $888.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Akkaraju SrinivasCIK 0001253170 | 10% Owner |
| Samsara BioCapital, L.P.CIK 0001699737 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | Common Stock | PPurchaseAcquired | +54,565 | $9.24 | +$504,180.6 | 7,868,745 | Indirect | |
| Jan 20, 2022 | Common Stock | PPurchaseAcquired | +43,105 | $8.92 | +$384,496.6 | 7,911,850 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.